BRAF and non-small cell lung carcinoma: Concerning the prognostic significance of BRAF mutations in NSCLC, as in colorectal [21] and papillary thyroid cancer [22], BRAFV600E-mutant tumors are associated with poor prognosis compared to the non-V600E ones [23].